Characterization of PINK1 processing, stability, and subcellular localization

Journal of Neurochemistry

Volumn 106, Issue 1, 2008, Pages 464-474

  Lin, William ^a   Kang, Un Jung ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b SBRI J 219 ^*  (United States)

Author keywords

Heat shock protein 90; Mitochondria; Parkinson's disease; PTEN induced putative kinase 1; Valinomycin

Indexed keywords

HEAT SHOCK PROTEIN 90; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME;

ARTICLE; CELL COMPARTMENTALIZATION; CYTOSOL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STABILITY;

CELL COMPARTMENTATION; CYTOSOL; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ISOFORMS; PROTEIN KINASES; PROTEIN TRANSPORT;

EID: 45249112594     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05398.x     Document Type: Article

References (44)

1. Abou-Sleiman P. M., Muqit M. M., McDonald N. Q. et al. (2006) A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann. Neurol. 60, 414 419.
2. Beilina A., Van Der Brug M., Ahmad R., Kesavapany S., Miller D. W., Petsko G. A. Cookson M. R. (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl Acad. Sci. USA 102, 5703 5708.
3. Bota D. A. Davies K. J. (2001) Protein degradation in mitochondria: implications for oxidative stress, aging and disease: a novel etiological classification of mitochondrial proteolytic disorders. Mitochondrion 1, 33 49.
4. Caplan A. J., Mandal A. K. Theodoraki M. A. (2007) Molecular chaperones and protein kinase quality control. Trends Cell Biol. 17, 87 92.
5. Citri A., Harari D., Shohat G. et al. (2006) Hsp90 recognizes a common surface on client kinases. J. Biol. Chem. 281, 14361 14369.
6. Clark I. E., Dodson M. W., Jiang C., Cao J. H., Huh J. R., Seol J. H., Yoo S. J., Hay B. A. Guo M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162 1166.
7. Deng H., Jankovic J., Guo Y., Xie W. Le W. (2005) Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem. Biophys. Res. Commun. 337, 1133 1138.
8. Djarmati A., Hedrich K., Svetel M., Lohnau T., Schwinger E., Romac S., Pramstaller P. P., Kostic V. Klein C. (2006) Heterozygous PINK1 mutations: a susceptibility factor for Parkinson disease? Mov. Disord. 21, 1526 1530.
9. Exner N., Treske B., Paquet D. et al. (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J. Neurosci. 27, 12413 12418.
10. Fan A. C., Bhangoo M. K. Young J. C. (2006) Hsp90 functions in the targeting and outer membrane translocation steps of Tom70-mediated mitochondrial import. J. Biol. Chem. 281, 33313 33324.
11. Gandhi S., Muqit M. M., Stanyer L. et al. (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain 129, 1720 1731.
12. Gasser T. (2005) Genetics of Parkinson's disease. Curr. Opin. Neurol. 18, 363 369.
13. Haque M. E., Thomas K. J., D'Souza C., Callaghan S., Kitada T., Slack R. S., Fraser P., Cookson M. R., Tandon A. Park D. S. (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc. Natl Acad. Sci. USA 105, 1716 1721.
14. Kitada T., Pisani A., Porter D. R., Yamaguchi H., Tscherter A., Martella G., Bonsi P., Zhang C., Pothos E. N. Shen J. (2007) Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc. Natl Acad. Sci. USA 104, 11441 11446.
15. Klein C., Lohmann-Hedrich K., Rogaeva E., Schlossmacher M. G. Lang A. E. (2007) Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol. 6, 652 662.
16. Knox C., Sass E., Neupert W. Pines O. (1998) Import into mitochondria, folding and retrograde movement of fumarase in yeast. J. Biol. Chem. 273, 25587 25593.
17. de Lau L. M. Breteler M. M. (2006) Epidemiology of Parkinson's disease. Lancet Neurol. 5, 525 535.
18. Matouschek A., Azem A., Ratliff K., Glick B. S., Schmid K. Schatz G. (1997) Active unfolding of precursor proteins during mitochondrial protein import. EMBO J. 16, 6727 6736.
19. Moriwaki Y., Kim Y. J., Ido Y., Misawa H., Kawashima K., Endo S. Takahasi R. (2008) L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner. Neurosci. Res. (DOI :).
20. Muqit M. M., Abou-Sleiman P. M., Saurin A. T. et al. (2006) Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J. Neurochem. 98, 156 169.
21. Park J., Kim S. Y., Cha G. H., Lee S. B., Kim S. Chung J. (2005) Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361C, 133 139.
22. Park J., Lee S. B., Lee S. et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157 1161.
23. Petit A., Kawarai T., Paitel E. et al. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280, 34025 34032.
24. Plun-Favreau H., Klupsch K., Moisoi N. et al. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat. Cell Biol. 9, 1243 1252.
25. Pridgeon J. W., Olzmann J. A., Chin L. S. Li L. (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5, e172.
26. Prodromou C. Pearl L. H. (2003) Structure and functional relationships of Hsp90. Curr. Cancer Drug Targets 3, 301 323.
27. Sass E., Blachinsky E., Karniely S. Pines O. (2001) Mitochondrial and cytosolic isoforms of yeast fumarase are derivatives of a single translation product and have identical amino termini. J. Biol. Chem. 276, 46111 46117.
28. Sass E., Karniely S. Pines O. (2003) Folding of fumarase during mitochondrial import determines its dual targeting in yeast. J. Biol. Chem. 278, 45109 45116.
29. Shen J., Chen X., Hendershot L. Prywes R. (2002) ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 3, 99 111.
30. Silvestri L., Caputo V., Bellacchio E., Atorino L., Dallapiccola B., Valente E. M. Casari G. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 14, 3477 3492.
31. Sim C. H., Lio D. S., Mok S. S., Masters C. L., Hill A. F., Culvenor J. G. Cheng H. C. (2006) C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum. Mol. Genet. 15, 3251 3262.
32. Takatori S., Ito G. Iwatsubo T. (2008) Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1. Neurosci. Lett. 430, 13 17.
33. Tan E. K. Skipper L. M. (2007) Pathogenic mutations in Parkinson disease. Hum. Mutat. 28, 641 653.
34. Tang B., Xiong H., Sun P. et al. (2006) Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum. Mol. Genet. 15, 1816 1825.
35. Truscott K. N., Brandner K. Pfanner N. (2003) Mechanisms of protein import into mitochondria. Curr. Biol. 13, R326 R337.
36. Valente E. M., Abou-Sleiman P. M., Caputo V. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158 1160.
37. Wang D., Qian L., Xiong H., Liu J., Neckameyer W. S., Oldham S., Xia K., Wang J., Bodmer R. Zhang Z. (2006) Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc. Natl Acad. Sci. USA 103, 13520 13525.
38. Weihofen A., Ostaszewski B., Minami Y. Selkoe D. J. (2008) Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. Hum. Mol. Genet. 17, 602 616.
39. Whitesell L. Lindquist S. L. (2005) HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 5, 761 772.
40. Wickner W. Schekman R. (2005) Protein translocation across biological membranes. Science 310, 1452 1456.
41. Yang Y., Gehrke S., Imai Y., Huang Z., Ouyang Y., Wang J. W., Yang L., Beal M. F., Vogel H. Lu B. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl Acad. Sci. USA 103, 10793 10798.
42. Young J. C., Hoogenraad N. J. Hartl F. U. (2003) Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell 112, 41 50.
43. Zadikoff C., Rogaeva E., Djarmati A., Sato C., Salehi-Rad S., St George-Hyslop P., Klein C. Lang A. E. (2006) Homozygous and heterozygous PINK1 mutations: considerations for diagnosis and care of Parkinson's disease patients. Mov. Disord. 21, 875 879.
44. Zhou H., Falkenburger B. H., Schulz J. B., Tieu K., Xu Z. Xia X. G. (2007) Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int. J. Biol. Sci. 3, 242 250.